By Nigam Arora & Dr. Natasha Arora Weekly Digest from The Arora Report is popular among serious investors and money managers because they have found studying insights from the prior week gives them an edge over the coming weeks. Here is the day by day rundown from the morning capsules
By Nigam Arora & Dr. Natasha Arora To gain an edge, this is what you need to know today. Powell Speaks The Truth Please click here for a chart of S&P 500 ETF (SPY) which represents the benchmark stock market index S&P 500 (SPX). Note the following: It is worth a reminder
By Nigam Arora & Dr. Natasha Arora Better Than Gold Standard In a Phase 3 study, Summit Therapeutics Inc’s (SMMT) drug showed a statistically significant 5.3 months of improvement in progression free survival versus Keytruda in treatment of PD-L1- positive advanced non-small cell lung cancer. Keytruda from MRK is the gold standard.
By Nigam Arora & Dr. Natasha Arora Weekly Digest from The Arora Report is popular among serious investors and money managers because they have found studying insights from the prior week gives them an edge over the coming weeks. Here is the day by day rundown from the morning capsules
By Nigam Arora & Dr. Natasha Arora To gain an edge, this is what you need to know today. The Power Of Market Mechanics Please click here for a chart of Meta stock (META). Note the following: The Morning Capsule is about the big picture, not an individual stock. The chart of
By Nigam Arora & Dr. Natasha Arora Weekly Digest from The Arora Report is popular among serious investors and money managers because they have found studying insights from the prior week gives them an edge over the coming weeks. Here is the day by day rundown from the morning capsules
By Nigam Arora & Dr. Natasha Arora To gain an edge, this is what you need to know today. Important Data Ahead Please click here for a chart of Nasdaq 100 ETF (QQQ). Note the following: The chart shows that Nasdaq 100 has pulled back after touching the low band of the resistance zone.
By Nigam Arora & Dr. Natasha Arora Intelligence to prepare you in advance to act advantageously when a signal to act arrives. Lucrative Opportunities Lucrative opportunities are ahead in personalized cancer vaccines. Several ideas are on our radar at The Arora Report. Cancer Vaccines Are Different A cancer vaccine is
By Nigam Arora & Dr. Natasha Arora To gain an edge, this is what you need to know now. Pay Attention To Putin On Taiwan If you are holding stocks such as Apple (AAPL), Tesla (TSLA), Starbucks (SBUX), Blackrock (BLK), Nike (NKE), and Nvidia (NVDA) or if you are holding
By Nigam Arora & Dr. Natasha Arora Weekly Digest from The Arora Report is popular among serious investors and money managers because they have found studying insights from the prior week gives them an edge over the coming weeks. Here is the day by day rundown from the morning capsules